FBR Affirms BioDelivery Sciences (BDSI) at 'Outperform' Following FDA Approval of BELBUCA
Tweet Send to a Friend
FBR affirms BioDelivery Sciences International, Inc. (NASDAQ: BDSI) with an Outperform rating and $17 price target after the company and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
